India to Canada: Furosemide Export Trade Route

The India to Canada Furosemide corridor is one of India's established pharmaceutical export routes, with 103 shipments documented worth a combined $5.1M USD. The route is dominated by EMCURE PHARMACEUTICALS LIMITED, which alone accounts for roughly 25% of all export value, reflecting the consolidated nature of India's furosemide manufacturing sector.

Across 14 active suppliers, the average shipment value stands at $49.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with furosemide's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 20.3%, placing it at rank #14 among India's top furosemide export destinations globally.

On the import side, key buyers of Indian furosemide in Canada include MARCAN PHARMACEUTICALS INC., , MARCAN PHARMACEUTICALS INC.,, STERIMAX INC and 22 others. MARCAN PHARMACEUTICALS INC., is the single largest importer with 12 shipments valued at $741.6K USD.

India's furosemide exports to Canada are driven primarily by a handful of large-scale manufacturers. EMCURE PHARMACEUTICALS LIMITED with 22 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 14 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — EMCURE PHARMACEUTICALS LIMITED, IPCA LABORATORIES LIMITED, EMCURE PHARMACEUTICALS LIMITED — together account for 59% of total trade value on this route. The average shipment value of $49.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicines mint-furosemide (fu and furosemide injection usp (10mg/ml) 4 ml , suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MARCAN PHARMACEUTICALS INC., is the largest importer with 12 shipments worth $741.6K USD — representing 14% of all furosemide imports from India on this route. A total of 25 buyers are active on this corridor.